Xeloda in combination with oxaliplatin shown to be effective in early colon cancer
- Details
- Category: Roche

Nycomed announces FDA filing for Daxas® in COPD
- Details
- Category: Nycomed

Novartis delivers strong operational performance in the first half of 2009
- Details
- Category: Novartis

- Pharmaceuticals an industry growth leader: Net sales up 12% (local currencies) in first half of 2009 on contributions from new products and expansion in all regions
- R&D maintains momentum: Anti-cancer therapy Afinitor introduced in the US, awaiting EU approval; new biologic Ilaris and OTC brand Prevacid 24HR gain US approvals; clinical trials set to start in July for A(H1N1) pandemic flu vaccine
- H1 2009 operating results advance well, but impacted negatively by currencies:
Pfizer Receives Approval From European Commission For Pending Acquisition Of Wyeth
- Details
- Category: Pfizer

Pfizer Announces New Phase 1 Data From Two Novel Compounds For Alzheimer's Disease
- Details
- Category: Pfizer

GSK announces new commitments to fight HIV/AIDS in Sub-Saharan Africa
- Details
- Category: GlaxoSmithKline

Abbott and GSK to Collaborate on Molecular Diagnostic Test
- Details
- Category: Abbott

More Pharma News ...
- Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effientâ¢
- Bayer acquires exclusive rights to Bioton's insulin SciLin®
- Denosumab Demonstrates Superiority Over Zometa(R) in Pivotal Phase 3 Head-to-Head Trial
- AstraZeneca to Advance AZD3480 in ADHD
- Bayer submits first-in-class estradiol-based oral contraceptive for approval in the US
- Lundbeck strengthens its research capabilities by acquiring ground-breaking Danish technologies
- Top 10 Tips for Staying Healthy When Money is Tight